Baldoza, Danilo R.

HRN: 23-31-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2023
09/05/2023
IV
500mg
QID
Hepatic Abscess
Checking Final Appropriateness 
08/15/2023
MEBENDAZOLE 500MG (TAB)
08/15/2023
08/15/2023
PO
Single Dose
Single Dose
Heptic Abscess
Checking Final Appropriateness 
08/17/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/17/2023
08/20/2023
PER NGT
500mg
OD
Cap Mr
Checking Final Appropriateness 
08/17/2023
CEFTRIAXONE 1G (VIAL)
08/17/2023
08/23/2023
IV
2g
OD
Cap Mr
Checking Final Appropriateness 
08/23/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/23/2023
08/30/2023
IV
500mg
Q6
Hepatic Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: